Replies to post #300865 on Avid Bioservices Inc (CDMO)

[sulaco]

Very reasonable post, CP, and definitely needed

PPHM is not Gilead, it's not McDonalds, and it's not the Altria Group.

But the stock is often compared to such companies. "No ROI, lagging PPS, BOD is terrible" etc. I understand these emotions, because money is involved.
Money provokes strong emotions.

But this is biotech. You sign up for it and you wait.

My brother says, "Only in the U.S. does instant gratification take too long."

We need to be patient and let the process work itself out. In my view, PS blockade will make billions for the Big Pharma anti-xyz'ers by tripling their responder footprint. That's good news for us.

But it's not going to happen overnight with the dynamics of the emerging I/O 2.0 combo paradigm.

A number of folks say they've been holding for 25+ years, and I respect that, but memories can be short.

Our understanding of Bavi has changed completely over the years. Initially, for me in 2011, I saw it only as very good lung cancer drug. Immunotherapy was but a whisper. We never talked about it on the Board.

But slowly and surely, the tide turned in our favor. And there's little indication that it won't continue turning in our favor.

The process is slow, I'm the first to agree. But good (new) things that weren't around for long-time investors years ago and now much closer to the corner.

Best,

Joe Six Pack

[DrRocker]

I appreciate the insights you have shared with the board over the years as you seem to have knowledge and experience well beyond the norm.
I am curious as to how you have fared with your PPHM investment to date.